The Purple

Posted on Posted in insight

In this edition, we explore Q1 2025 securities lending trends, spotlight APAC’s standout 27% revenue growth, introduce EquiLend’s Short Squeeze Score, examine corporate bond short interest signals and highlight Korean short selling performance.

EquiLend Awarded Global Data Provider and Regulatory Solution of the Year at the SFT Awards 2025

Posted on Posted in insight

Insight 10 JULY 2025 SFT AWARDS EquiLend Awarded Global Data Provider and Regulatory Solution of the Year 2025 at The Annual SFT Awards EquiLend is proud to announce two significant wins at the recent Securities Finance Awards 2025! 🏆 Global Data Provider of the Year 🏆 Regulatory Solution of the Year This recognition is an […]

Monthly Securities Finance Market Review: June 2025

Posted on Posted in insight

Insight Aug 2025 Vaibhav Garg Shaping Smarter Securities Finance Strategies with EquiLend Real-Time Data Real-time data unlocks faster decision-making, stronger risk management and more profitable trading strategies backed by continuous, real-time data flow. In today’s compressed settlement cycles, volatile markets and regulatory-driven deadlines, access to intraday insights is the only way to capture opportunities and […]

Market Flash on SMMT

Posted on Posted in insight

EquiLend Data & Analytics identifies Summit Therapeutics as a prime short squeeze candidate, with its squeeze score surging 43.0 points to 66 in just one month. With utilization approaching 78.98% and elevated borrow fees, short sellers are facing mounting pressure as positive clinical trial results drive momentum.